Wird geladen...
Bacillus Calmette–Guérin Immunotherapy for Cancer
Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer and other neoplasms. The use of BCG has been shown to...
Gespeichert in:
| Veröffentlicht in: | Vaccines (Basel) |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147207/ https://ncbi.nlm.nih.gov/pubmed/34062708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050439 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|